HomeNewsOpinionCOVID-19 | Can G-20 provide the right platform for a global response?

COVID-19 | Can G-20 provide the right platform for a global response?

As the world economy is entering recession, the G-20 will have to play a decisive role in mobilising resources and provide direction to major economies and multilateral institutions.

May 11, 2020 / 18:19 IST
Story continues below Advertisement
Representative Image
Representative Image

With the commitment of over $5 trillion, the leaders of the 20 largest economies of the world have assured to do whatever it takes to overcome the COVID-19 pandemic. At the extraordinary virtual leaders’ summit called by the Saudi Arabian presidency, the G-20 leaders promised to use all available policy tools to minimise the economic and social damage, restore global growth and maintain market stability. They have also agreed to share all relevant information, expand manufacturing capacity for medical supplies in addition to strengthening the World Health Organization’s (WHO’s) mandate in delivering diagnostic tools, medicines and vaccines.

Immediately after the summit, International Monetary Fund (IMF) Managing Director Kristalina Georgieva declared “it is now clear that we have entered a recession as bad, or worse than in 2009”. It is not just about Europe and the United States; she highlighted that a wide range of problems are building up in emerging markets and developing economies as well. There is drop in commodity prices in addition to $83 billion capital outflows from emerging markets. More than 80 countries have requested the IMF for emergency financing, and emerging markets may need at least $2.5 trillion.

Story continues below Advertisement

The United States, the hardest hit by the virus, has announced a $2-trillion stimulus package. In Europe, the current epicentre of the epidemic, Germany and France announced their stimulus for €750 billion and €45 billion respectively. To protect businesses and workers, Britain has announced four packages worth 65 billion pounds in tax cuts and spending. The European Central Bank is spending  €750 billion in bond purchases to provide more liquidity to member states. The European Union leaders, however, have yet to agree on a common financial response, including the so-called corona bonds — an EU-backed mechanism to raise common debt. As EU is preparing for major economic shocks (reduction in real GDP growth in 2020 by 2.5 percentage points), the organisation has promised to everything at its disposal to minimise the impact.

The Brexit transition period is likely to be extended further. At the moment policy makers on both sides are busy elsewhere. Even Brexit negotiators are down with coronavirus.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show